nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—RARB—lung cancer	0.236	0.595	CbGaD
Tretinoin—CYP2A6—lung cancer	0.0946	0.238	CbGaD
Tretinoin—CYP1A1—lung cancer	0.0663	0.167	CbGaD
Tretinoin—CYP4A11—Cisplatin—lung cancer	0.0505	0.168	CbGbCtD
Tretinoin—CYP1A1—Gefitinib—lung cancer	0.0211	0.0704	CbGbCtD
Tretinoin—CYP3A5—Gefitinib—lung cancer	0.0127	0.0422	CbGbCtD
Tretinoin—CYP1A1—Erlotinib—lung cancer	0.0125	0.0416	CbGbCtD
Tretinoin—CYP3A5—Teniposide—lung cancer	0.0123	0.0409	CbGbCtD
Tretinoin—CYP3A7—Paclitaxel—lung cancer	0.00916	0.0305	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.00916	0.0305	CbGbCtD
Tretinoin—CYP3A7—Irinotecan—lung cancer	0.00903	0.0301	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.00903	0.0301	CbGbCtD
Tretinoin—CYP2B6—Irinotecan—lung cancer	0.0086	0.0286	CbGbCtD
Tretinoin—CYP2C9—Gefitinib—lung cancer	0.00851	0.0283	CbGbCtD
Tretinoin—CYP2C9—Teniposide—lung cancer	0.00825	0.0275	CbGbCtD
Tretinoin—CYP3A5—Crizotinib—lung cancer	0.00778	0.0259	CbGbCtD
Tretinoin—CYP3A5—Erlotinib—lung cancer	0.0075	0.025	CbGbCtD
Tretinoin—CYP2C8—Erlotinib—lung cancer	0.00721	0.024	CbGbCtD
Tretinoin—CYP2B6—Cisplatin—lung cancer	0.00701	0.0233	CbGbCtD
Tretinoin—CYP3A5—Paclitaxel—lung cancer	0.00687	0.0229	CbGbCtD
Tretinoin—CYP3A5—Irinotecan—lung cancer	0.00678	0.0225	CbGbCtD
Tretinoin—CYP3A7—Docetaxel—lung cancer	0.00662	0.022	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.00662	0.022	CbGbCtD
Tretinoin—CYP2C8—Paclitaxel—lung cancer	0.0066	0.022	CbGbCtD
Tretinoin—CYP3A5—Etoposide—lung cancer	0.00543	0.0181	CbGbCtD
Tretinoin—CYP3A4—Topotecan—lung cancer	0.00541	0.018	CbGbCtD
Tretinoin—CYP2C8—Etoposide—lung cancer	0.00522	0.0174	CbGbCtD
Tretinoin—CYP3A5—Docetaxel—lung cancer	0.00497	0.0165	CbGbCtD
Tretinoin—CYP3A4—Gefitinib—lung cancer	0.00495	0.0165	CbGbCtD
Tretinoin—CYP3A4—Teniposide—lung cancer	0.0048	0.016	CbGbCtD
Tretinoin—CYP2B6—Doxorubicin—lung cancer	0.0047	0.0156	CbGbCtD
Tretinoin—CYP2C9—Paclitaxel—lung cancer	0.00461	0.0153	CbGbCtD
Tretinoin—CYP3A4—Vinorelbine—lung cancer	0.00381	0.0127	CbGbCtD
Tretinoin—GPRC5A—respiratory system—lung cancer	0.00371	0.082	CbGeAlD
Tretinoin—CYP2C9—Cisplatin—lung cancer	0.0037	0.0123	CbGbCtD
Tretinoin—CYP3A4—Crizotinib—lung cancer	0.00303	0.0101	CbGbCtD
Tretinoin—CYP3A4—Erlotinib—lung cancer	0.00293	0.00974	CbGbCtD
Tretinoin—RARRES1—mammary gland—lung cancer	0.00282	0.0623	CbGeAlD
Tretinoin—CYP3A4—Paclitaxel—lung cancer	0.00268	0.00891	CbGbCtD
Tretinoin—CYP3A4—Irinotecan—lung cancer	0.00264	0.00879	CbGbCtD
Tretinoin—CYP3A4—Vinblastine—lung cancer	0.00235	0.00782	CbGbCtD
Tretinoin—CYP3A4—Etoposide—lung cancer	0.00212	0.00704	CbGbCtD
Tretinoin—GPRC5A—lung—lung cancer	0.00197	0.0436	CbGeAlD
Tretinoin—CYP3A4—Docetaxel—lung cancer	0.00194	0.00644	CbGbCtD
Tretinoin—NR0B1—respiratory system—lung cancer	0.00161	0.0357	CbGeAlD
Tretinoin—ALDH1A1—mammary gland—lung cancer	0.00157	0.0347	CbGeAlD
Tretinoin—RARRES1—bronchus—lung cancer	0.00154	0.0341	CbGeAlD
Tretinoin—CYP3A4—Doxorubicin—lung cancer	0.00144	0.0048	CbGbCtD
Tretinoin—ALDH1A2—respiratory system—lung cancer	0.00144	0.0318	CbGeAlD
Tretinoin—RARRES1—trachea—lung cancer	0.00139	0.0307	CbGeAlD
Tretinoin—RARRES1—cardiac atrium—lung cancer	0.0013	0.0288	CbGeAlD
Tretinoin—RARA—mammary gland—lung cancer	0.00129	0.0286	CbGeAlD
Tretinoin—Isotretinoin—RARB—lung cancer	0.00119	0.324	CrCbGaD
Tretinoin—CRABP1—bronchus—lung cancer	0.00114	0.0253	CbGeAlD
Tretinoin—RARB—respiratory system—lung cancer	0.00112	0.0248	CbGeAlD
Tretinoin—ALDH1A1—respiratory system—lung cancer	0.00105	0.0231	CbGeAlD
Tretinoin—CRABP2—bronchus—lung cancer	0.00103	0.0229	CbGeAlD
Tretinoin—CRABP1—trachea—lung cancer	0.00103	0.0227	CbGeAlD
Tretinoin—Acitretin—RARB—lung cancer	0.00101	0.276	CrCbGaD
Tretinoin—RARRES1—lung—lung cancer	0.000996	0.022	CbGeAlD
Tretinoin—Alitretinoin—RARB—lung cancer	0.00097	0.264	CrCbGaD
Tretinoin—CRABP2—trachea—lung cancer	0.000928	0.0205	CbGeAlD
Tretinoin—RARB—bronchus—lung cancer	0.000924	0.0204	CbGeAlD
Tretinoin—ALDH1A1—Podofilox—Teniposide—lung cancer	0.000923	0.335	CbGdCrCtD
Tretinoin—RARG—respiratory system—lung cancer	0.000916	0.0203	CbGeAlD
Tretinoin—RARA—respiratory system—lung cancer	0.000861	0.019	CbGeAlD
Tretinoin—ALDH1A1—bronchus—lung cancer	0.000861	0.019	CbGeAlD
Tretinoin—NR0B1—lung—lung cancer	0.000858	0.019	CbGeAlD
Tretinoin—ALDH1A1—trachea—lung cancer	0.000773	0.0171	CbGeAlD
Tretinoin—ALDH1A2—lung—lung cancer	0.000764	0.0169	CbGeAlD
Tretinoin—CYP2C18—bronchus—lung cancer	0.000757	0.0167	CbGeAlD
Tretinoin—ALDH1A1—cardiac atrium—lung cancer	0.000726	0.0161	CbGeAlD
Tretinoin—RXRB—cardiac atrium—lung cancer	0.000716	0.0158	CbGeAlD
Tretinoin—RARRES1—lymph node—lung cancer	0.000681	0.0151	CbGeAlD
Tretinoin—CRABP2—lung—lung cancer	0.000667	0.0147	CbGeAlD
Tretinoin—ALDH1A1—bone marrow—lung cancer	0.000613	0.0136	CbGeAlD
Tretinoin—RARB—lung—lung cancer	0.000596	0.0132	CbGeAlD
Tretinoin—ALDH1A1—lung—lung cancer	0.000556	0.0123	CbGeAlD
Tretinoin—ALDH1A1—Podofilox—Etoposide—lung cancer	0.000549	0.199	CbGdCrCtD
Tretinoin—ALDH1A1—Teniposide—Etoposide—lung cancer	0.000549	0.199	CbGdCrCtD
Tretinoin—RXRB—lung—lung cancer	0.000548	0.0121	CbGeAlD
Tretinoin—ALDH1A2—lymph node—lung cancer	0.000523	0.0116	CbGeAlD
Tretinoin—CYP2C8—mammary gland—lung cancer	0.000512	0.0113	CbGeAlD
Tretinoin—RARA—bone marrow—lung cancer	0.000505	0.0112	CbGeAlD
Tretinoin—RARG—lung—lung cancer	0.000486	0.0108	CbGeAlD
Tretinoin—ALDH1A1—Vinblastine—Vinorelbine—lung cancer	0.000472	0.171	CbGdCrCtD
Tretinoin—RARA—lung—lung cancer	0.000457	0.0101	CbGeAlD
Tretinoin—CYP2C9—mammary gland—lung cancer	0.000455	0.0101	CbGeAlD
Tretinoin—RARB—lymph node—lung cancer	0.000408	0.00902	CbGeAlD
Tretinoin—ALDH1A1—lymph node—lung cancer	0.00038	0.0084	CbGeAlD
Tretinoin—RARG—lymph node—lung cancer	0.000333	0.00736	CbGeAlD
Tretinoin—CYP2A6—lung—lung cancer	0.000323	0.00714	CbGeAlD
Tretinoin—CYP1A1—respiratory system—lung cancer	0.000315	0.00697	CbGeAlD
Tretinoin—RARA—lymph node—lung cancer	0.000313	0.00692	CbGeAlD
Tretinoin—CYP3A5—respiratory system—lung cancer	0.000308	0.00681	CbGeAlD
Tretinoin—CYP2B6—respiratory system—lung cancer	0.000306	0.00677	CbGeAlD
Tretinoin—ALDH1A1—Idarubicin—Doxorubicin—lung cancer	0.000265	0.096	CbGdCrCtD
Tretinoin—CYP1A1—epithelium—lung cancer	0.000263	0.00582	CbGeAlD
Tretinoin—CYP1A1—bronchus—lung cancer	0.000259	0.00573	CbGeAlD
Tretinoin—CYP2B6—bronchus—lung cancer	0.000252	0.00557	CbGeAlD
Tretinoin—CYP1A1—trachea—lung cancer	0.000233	0.00515	CbGeAlD
Tretinoin—CYP1A1—cardiac atrium—lung cancer	0.000219	0.00484	CbGeAlD
Tretinoin—Vitamin A—CYP1A1—lung cancer	0.000199	0.0541	CrCbGaD
Tretinoin—CYP1A1—lung—lung cancer	0.000167	0.0037	CbGeAlD
Tretinoin—CYP3A5—lung—lung cancer	0.000164	0.00362	CbGeAlD
Tretinoin—CYP2B6—lung—lung cancer	0.000163	0.00359	CbGeAlD
Tretinoin—Acitretin—ALB—lung cancer	0.000158	0.043	CrCbGaD
Tretinoin—Alitretinoin—ABCB1—lung cancer	0.000145	0.0394	CrCbGaD
Tretinoin—CYP1A1—lymph node—lung cancer	0.000114	0.00253	CbGeAlD
Tretinoin—Haemorrhage—Methotrexate—lung cancer	2.7e-05	0.000187	CcSEcCtD
Tretinoin—Hepatitis—Methotrexate—lung cancer	2.7e-05	0.000187	CcSEcCtD
Tretinoin—Pollakiuria—Doxorubicin—lung cancer	2.7e-05	0.000187	CcSEcCtD
Tretinoin—Asthenia—Gemcitabine—lung cancer	2.69e-05	0.000187	CcSEcCtD
Tretinoin—Constipation—Paclitaxel—lung cancer	2.69e-05	0.000186	CcSEcCtD
Tretinoin—Pain—Paclitaxel—lung cancer	2.69e-05	0.000186	CcSEcCtD
Tretinoin—Confusional state—Docetaxel—lung cancer	2.69e-05	0.000186	CcSEcCtD
Tretinoin—Pharyngitis—Methotrexate—lung cancer	2.68e-05	0.000186	CcSEcCtD
Tretinoin—Urinary tract disorder—Methotrexate—lung cancer	2.67e-05	0.000185	CcSEcCtD
Tretinoin—Photosensitivity reaction—Doxorubicin—lung cancer	2.67e-05	0.000185	CcSEcCtD
Tretinoin—Anaphylactic shock—Docetaxel—lung cancer	2.66e-05	0.000185	CcSEcCtD
Tretinoin—Oedema—Docetaxel—lung cancer	2.66e-05	0.000185	CcSEcCtD
Tretinoin—Weight increased—Doxorubicin—lung cancer	2.66e-05	0.000184	CcSEcCtD
Tretinoin—Pruritus—Gemcitabine—lung cancer	2.66e-05	0.000184	CcSEcCtD
Tretinoin—Urethral disorder—Methotrexate—lung cancer	2.65e-05	0.000184	CcSEcCtD
Tretinoin—Infection—Docetaxel—lung cancer	2.65e-05	0.000183	CcSEcCtD
Tretinoin—Weight decreased—Doxorubicin—lung cancer	2.64e-05	0.000183	CcSEcCtD
Tretinoin—Feeling abnormal—Etoposide—lung cancer	2.64e-05	0.000183	CcSEcCtD
Tretinoin—Diarrhoea—Irinotecan—lung cancer	2.64e-05	0.000183	CcSEcCtD
Tretinoin—Pneumonia—Doxorubicin—lung cancer	2.62e-05	0.000182	CcSEcCtD
Tretinoin—Gastrointestinal pain—Etoposide—lung cancer	2.62e-05	0.000182	CcSEcCtD
Tretinoin—Shock—Docetaxel—lung cancer	2.62e-05	0.000182	CcSEcCtD
Tretinoin—Nervous system disorder—Docetaxel—lung cancer	2.61e-05	0.000181	CcSEcCtD
Tretinoin—Thrombocytopenia—Docetaxel—lung cancer	2.61e-05	0.000181	CcSEcCtD
Tretinoin—Infestation—Doxorubicin—lung cancer	2.61e-05	0.000181	CcSEcCtD
Tretinoin—Drowsiness—Doxorubicin—lung cancer	2.61e-05	0.000181	CcSEcCtD
Tretinoin—Infestation NOS—Doxorubicin—lung cancer	2.61e-05	0.000181	CcSEcCtD
Tretinoin—Visual impairment—Methotrexate—lung cancer	2.6e-05	0.000181	CcSEcCtD
Tretinoin—Tachycardia—Docetaxel—lung cancer	2.6e-05	0.00018	CcSEcCtD
Tretinoin—Feeling abnormal—Paclitaxel—lung cancer	2.59e-05	0.00018	CcSEcCtD
Tretinoin—Skin disorder—Docetaxel—lung cancer	2.59e-05	0.000179	CcSEcCtD
Tretinoin—Stevens-Johnson syndrome—Doxorubicin—lung cancer	2.58e-05	0.000179	CcSEcCtD
Tretinoin—Hypersensitivity—Cisplatin—lung cancer	2.58e-05	0.000179	CcSEcCtD
Tretinoin—Gastrointestinal pain—Paclitaxel—lung cancer	2.57e-05	0.000178	CcSEcCtD
Tretinoin—Diarrhoea—Gemcitabine—lung cancer	2.57e-05	0.000178	CcSEcCtD
Tretinoin—Renal failure—Doxorubicin—lung cancer	2.56e-05	0.000178	CcSEcCtD
Tretinoin—Erythema multiforme—Methotrexate—lung cancer	2.55e-05	0.000177	CcSEcCtD
Tretinoin—Neuropathy peripheral—Doxorubicin—lung cancer	2.55e-05	0.000177	CcSEcCtD
Tretinoin—Dizziness—Irinotecan—lung cancer	2.55e-05	0.000177	CcSEcCtD
Tretinoin—Urticaria—Etoposide—lung cancer	2.55e-05	0.000177	CcSEcCtD
Tretinoin—Stomatitis—Doxorubicin—lung cancer	2.54e-05	0.000176	CcSEcCtD
Tretinoin—Anorexia—Docetaxel—lung cancer	2.54e-05	0.000176	CcSEcCtD
Tretinoin—Abdominal pain—Etoposide—lung cancer	2.53e-05	0.000176	CcSEcCtD
Tretinoin—Body temperature increased—Etoposide—lung cancer	2.53e-05	0.000176	CcSEcCtD
Tretinoin—Urinary tract infection—Doxorubicin—lung cancer	2.53e-05	0.000176	CcSEcCtD
Tretinoin—Conjunctivitis—Doxorubicin—lung cancer	2.53e-05	0.000176	CcSEcCtD
Tretinoin—Eye disorder—Methotrexate—lung cancer	2.53e-05	0.000175	CcSEcCtD
Tretinoin—Tinnitus—Methotrexate—lung cancer	2.52e-05	0.000175	CcSEcCtD
Tretinoin—Asthenia—Cisplatin—lung cancer	2.51e-05	0.000174	CcSEcCtD
Tretinoin—Sweating—Doxorubicin—lung cancer	2.5e-05	0.000173	CcSEcCtD
Tretinoin—Urticaria—Paclitaxel—lung cancer	2.5e-05	0.000173	CcSEcCtD
Tretinoin—Hypotension—Docetaxel—lung cancer	2.49e-05	0.000173	CcSEcCtD
Tretinoin—Haematuria—Doxorubicin—lung cancer	2.49e-05	0.000172	CcSEcCtD
Tretinoin—Body temperature increased—Paclitaxel—lung cancer	2.48e-05	0.000172	CcSEcCtD
Tretinoin—Abdominal pain—Paclitaxel—lung cancer	2.48e-05	0.000172	CcSEcCtD
Tretinoin—Epistaxis—Doxorubicin—lung cancer	2.46e-05	0.00017	CcSEcCtD
Tretinoin—Angiopathy—Methotrexate—lung cancer	2.45e-05	0.00017	CcSEcCtD
Tretinoin—Vomiting—Irinotecan—lung cancer	2.45e-05	0.00017	CcSEcCtD
Tretinoin—Sinusitis—Doxorubicin—lung cancer	2.45e-05	0.00017	CcSEcCtD
Tretinoin—Agranulocytosis—Doxorubicin—lung cancer	2.43e-05	0.000169	CcSEcCtD
Tretinoin—Rash—Irinotecan—lung cancer	2.43e-05	0.000168	CcSEcCtD
Tretinoin—Dermatitis—Irinotecan—lung cancer	2.43e-05	0.000168	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Docetaxel—lung cancer	2.43e-05	0.000168	CcSEcCtD
Tretinoin—Chills—Methotrexate—lung cancer	2.42e-05	0.000168	CcSEcCtD
Tretinoin—Headache—Irinotecan—lung cancer	2.41e-05	0.000167	CcSEcCtD
Tretinoin—Insomnia—Docetaxel—lung cancer	2.41e-05	0.000167	CcSEcCtD
Tretinoin—Diarrhoea—Cisplatin—lung cancer	2.39e-05	0.000166	CcSEcCtD
Tretinoin—Paraesthesia—Docetaxel—lung cancer	2.39e-05	0.000166	CcSEcCtD
Tretinoin—Alopecia—Methotrexate—lung cancer	2.39e-05	0.000166	CcSEcCtD
Tretinoin—Vomiting—Gemcitabine—lung cancer	2.39e-05	0.000165	CcSEcCtD
Tretinoin—Dyspnoea—Docetaxel—lung cancer	2.37e-05	0.000165	CcSEcCtD
Tretinoin—Somnolence—Docetaxel—lung cancer	2.37e-05	0.000164	CcSEcCtD
Tretinoin—Mental disorder—Methotrexate—lung cancer	2.37e-05	0.000164	CcSEcCtD
Tretinoin—Rash—Gemcitabine—lung cancer	2.37e-05	0.000164	CcSEcCtD
Tretinoin—Dermatitis—Gemcitabine—lung cancer	2.36e-05	0.000164	CcSEcCtD
Tretinoin—Hypersensitivity—Etoposide—lung cancer	2.36e-05	0.000164	CcSEcCtD
Tretinoin—Erythema—Methotrexate—lung cancer	2.35e-05	0.000163	CcSEcCtD
Tretinoin—Malnutrition—Methotrexate—lung cancer	2.35e-05	0.000163	CcSEcCtD
Tretinoin—Haemoglobin—Doxorubicin—lung cancer	2.35e-05	0.000163	CcSEcCtD
Tretinoin—Headache—Gemcitabine—lung cancer	2.35e-05	0.000163	CcSEcCtD
Tretinoin—Dyspepsia—Docetaxel—lung cancer	2.34e-05	0.000163	CcSEcCtD
Tretinoin—Haemorrhage—Doxorubicin—lung cancer	2.34e-05	0.000162	CcSEcCtD
Tretinoin—Hepatitis—Doxorubicin—lung cancer	2.34e-05	0.000162	CcSEcCtD
Tretinoin—Hypoaesthesia—Doxorubicin—lung cancer	2.33e-05	0.000161	CcSEcCtD
Tretinoin—Pharyngitis—Doxorubicin—lung cancer	2.32e-05	0.000161	CcSEcCtD
Tretinoin—Decreased appetite—Docetaxel—lung cancer	2.32e-05	0.000161	CcSEcCtD
Tretinoin—Hypersensitivity—Paclitaxel—lung cancer	2.32e-05	0.000161	CcSEcCtD
Tretinoin—Urinary tract disorder—Doxorubicin—lung cancer	2.31e-05	0.00016	CcSEcCtD
Tretinoin—Oedema peripheral—Doxorubicin—lung cancer	2.3e-05	0.00016	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Docetaxel—lung cancer	2.3e-05	0.000159	CcSEcCtD
Tretinoin—Asthenia—Etoposide—lung cancer	2.3e-05	0.000159	CcSEcCtD
Tretinoin—Fatigue—Docetaxel—lung cancer	2.3e-05	0.000159	CcSEcCtD
Tretinoin—Urethral disorder—Doxorubicin—lung cancer	2.29e-05	0.000159	CcSEcCtD
Tretinoin—Nausea—Irinotecan—lung cancer	2.29e-05	0.000159	CcSEcCtD
Tretinoin—Constipation—Docetaxel—lung cancer	2.28e-05	0.000158	CcSEcCtD
Tretinoin—Pain—Docetaxel—lung cancer	2.28e-05	0.000158	CcSEcCtD
Tretinoin—Back pain—Methotrexate—lung cancer	2.28e-05	0.000158	CcSEcCtD
Tretinoin—Pruritus—Etoposide—lung cancer	2.27e-05	0.000157	CcSEcCtD
Tretinoin—Visual impairment—Doxorubicin—lung cancer	2.25e-05	0.000156	CcSEcCtD
Tretinoin—Asthenia—Paclitaxel—lung cancer	2.25e-05	0.000156	CcSEcCtD
Tretinoin—Nausea—Gemcitabine—lung cancer	2.23e-05	0.000155	CcSEcCtD
Tretinoin—Vomiting—Cisplatin—lung cancer	2.22e-05	0.000154	CcSEcCtD
Tretinoin—Pruritus—Paclitaxel—lung cancer	2.22e-05	0.000154	CcSEcCtD
Tretinoin—Vision blurred—Methotrexate—lung cancer	2.22e-05	0.000154	CcSEcCtD
Tretinoin—Erythema multiforme—Doxorubicin—lung cancer	2.21e-05	0.000153	CcSEcCtD
Tretinoin—Rash—Cisplatin—lung cancer	2.21e-05	0.000153	CcSEcCtD
Tretinoin—Dermatitis—Cisplatin—lung cancer	2.2e-05	0.000153	CcSEcCtD
Tretinoin—Feeling abnormal—Docetaxel—lung cancer	2.19e-05	0.000152	CcSEcCtD
Tretinoin—Diarrhoea—Etoposide—lung cancer	2.19e-05	0.000152	CcSEcCtD
Tretinoin—Eye disorder—Doxorubicin—lung cancer	2.19e-05	0.000152	CcSEcCtD
Tretinoin—Ill-defined disorder—Methotrexate—lung cancer	2.18e-05	0.000151	CcSEcCtD
Tretinoin—Tinnitus—Doxorubicin—lung cancer	2.18e-05	0.000151	CcSEcCtD
Tretinoin—Gastrointestinal pain—Docetaxel—lung cancer	2.18e-05	0.000151	CcSEcCtD
Tretinoin—Anaemia—Methotrexate—lung cancer	2.17e-05	0.000151	CcSEcCtD
Tretinoin—Flushing—Doxorubicin—lung cancer	2.17e-05	0.000151	CcSEcCtD
Tretinoin—Diarrhoea—Paclitaxel—lung cancer	2.15e-05	0.000149	CcSEcCtD
Tretinoin—Angiopathy—Doxorubicin—lung cancer	2.12e-05	0.000147	CcSEcCtD
Tretinoin—Malaise—Methotrexate—lung cancer	2.12e-05	0.000147	CcSEcCtD
Tretinoin—Dizziness—Etoposide—lung cancer	2.12e-05	0.000147	CcSEcCtD
Tretinoin—Abdominal pain—Docetaxel—lung cancer	2.11e-05	0.000146	CcSEcCtD
Tretinoin—Body temperature increased—Docetaxel—lung cancer	2.11e-05	0.000146	CcSEcCtD
Tretinoin—Chills—Doxorubicin—lung cancer	2.1e-05	0.000146	CcSEcCtD
Tretinoin—Arrhythmia—Doxorubicin—lung cancer	2.09e-05	0.000145	CcSEcCtD
Tretinoin—Dizziness—Paclitaxel—lung cancer	2.08e-05	0.000144	CcSEcCtD
Tretinoin—Nausea—Cisplatin—lung cancer	2.08e-05	0.000144	CcSEcCtD
Tretinoin—Alopecia—Doxorubicin—lung cancer	2.07e-05	0.000143	CcSEcCtD
Tretinoin—Cough—Methotrexate—lung cancer	2.05e-05	0.000142	CcSEcCtD
Tretinoin—Mental disorder—Doxorubicin—lung cancer	2.05e-05	0.000142	CcSEcCtD
Tretinoin—Convulsion—Methotrexate—lung cancer	2.04e-05	0.000141	CcSEcCtD
Tretinoin—Vomiting—Etoposide—lung cancer	2.04e-05	0.000141	CcSEcCtD
Tretinoin—Erythema—Doxorubicin—lung cancer	2.04e-05	0.000141	CcSEcCtD
Tretinoin—Malnutrition—Doxorubicin—lung cancer	2.04e-05	0.000141	CcSEcCtD
Tretinoin—Rash—Etoposide—lung cancer	2.02e-05	0.00014	CcSEcCtD
Tretinoin—Dermatitis—Etoposide—lung cancer	2.02e-05	0.00014	CcSEcCtD
Tretinoin—Headache—Etoposide—lung cancer	2.01e-05	0.000139	CcSEcCtD
Tretinoin—Flatulence—Doxorubicin—lung cancer	2.01e-05	0.000139	CcSEcCtD
Tretinoin—Myalgia—Methotrexate—lung cancer	2e-05	0.000139	CcSEcCtD
Tretinoin—Arthralgia—Methotrexate—lung cancer	2e-05	0.000139	CcSEcCtD
Tretinoin—Chest pain—Methotrexate—lung cancer	2e-05	0.000139	CcSEcCtD
Tretinoin—Tension—Doxorubicin—lung cancer	2e-05	0.000139	CcSEcCtD
Tretinoin—Vomiting—Paclitaxel—lung cancer	2e-05	0.000139	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	1.99e-05	0.000138	CcSEcCtD
Tretinoin—Rash—Paclitaxel—lung cancer	1.98e-05	0.000137	CcSEcCtD
Tretinoin—Dermatitis—Paclitaxel—lung cancer	1.98e-05	0.000137	CcSEcCtD
Tretinoin—Discomfort—Methotrexate—lung cancer	1.98e-05	0.000137	CcSEcCtD
Tretinoin—Nervousness—Doxorubicin—lung cancer	1.98e-05	0.000137	CcSEcCtD
Tretinoin—Back pain—Doxorubicin—lung cancer	1.97e-05	0.000137	CcSEcCtD
Tretinoin—Headache—Paclitaxel—lung cancer	1.97e-05	0.000136	CcSEcCtD
Tretinoin—Hypersensitivity—Docetaxel—lung cancer	1.96e-05	0.000136	CcSEcCtD
Tretinoin—Confusional state—Methotrexate—lung cancer	1.94e-05	0.000134	CcSEcCtD
Tretinoin—Anaphylactic shock—Methotrexate—lung cancer	1.92e-05	0.000133	CcSEcCtD
Tretinoin—Vision blurred—Doxorubicin—lung cancer	1.92e-05	0.000133	CcSEcCtD
Tretinoin—Asthenia—Docetaxel—lung cancer	1.91e-05	0.000132	CcSEcCtD
Tretinoin—Infection—Methotrexate—lung cancer	1.91e-05	0.000132	CcSEcCtD
Tretinoin—Nausea—Etoposide—lung cancer	1.9e-05	0.000132	CcSEcCtD
Tretinoin—Ill-defined disorder—Doxorubicin—lung cancer	1.89e-05	0.000131	CcSEcCtD
Tretinoin—Pruritus—Docetaxel—lung cancer	1.88e-05	0.000131	CcSEcCtD
Tretinoin—Nervous system disorder—Methotrexate—lung cancer	1.88e-05	0.000131	CcSEcCtD
Tretinoin—Anaemia—Doxorubicin—lung cancer	1.88e-05	0.000131	CcSEcCtD
Tretinoin—Thrombocytopenia—Methotrexate—lung cancer	1.88e-05	0.00013	CcSEcCtD
Tretinoin—Agitation—Doxorubicin—lung cancer	1.87e-05	0.00013	CcSEcCtD
Tretinoin—Nausea—Paclitaxel—lung cancer	1.87e-05	0.000129	CcSEcCtD
Tretinoin—Skin disorder—Methotrexate—lung cancer	1.86e-05	0.000129	CcSEcCtD
Tretinoin—Hyperhidrosis—Methotrexate—lung cancer	1.86e-05	0.000129	CcSEcCtD
Tretinoin—Malaise—Doxorubicin—lung cancer	1.84e-05	0.000127	CcSEcCtD
Tretinoin—Anorexia—Methotrexate—lung cancer	1.83e-05	0.000127	CcSEcCtD
Tretinoin—Syncope—Doxorubicin—lung cancer	1.83e-05	0.000127	CcSEcCtD
Tretinoin—Diarrhoea—Docetaxel—lung cancer	1.82e-05	0.000126	CcSEcCtD
Tretinoin—Palpitations—Doxorubicin—lung cancer	1.8e-05	0.000125	CcSEcCtD
Tretinoin—Hypotension—Methotrexate—lung cancer	1.79e-05	0.000124	CcSEcCtD
Tretinoin—Loss of consciousness—Doxorubicin—lung cancer	1.79e-05	0.000124	CcSEcCtD
Tretinoin—Cough—Doxorubicin—lung cancer	1.78e-05	0.000123	CcSEcCtD
Tretinoin—Convulsion—Doxorubicin—lung cancer	1.76e-05	0.000122	CcSEcCtD
Tretinoin—Dizziness—Docetaxel—lung cancer	1.76e-05	0.000122	CcSEcCtD
Tretinoin—Hypertension—Doxorubicin—lung cancer	1.76e-05	0.000122	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Methotrexate—lung cancer	1.75e-05	0.000121	CcSEcCtD
Tretinoin—Insomnia—Methotrexate—lung cancer	1.74e-05	0.00012	CcSEcCtD
Tretinoin—Arthralgia—Doxorubicin—lung cancer	1.73e-05	0.00012	CcSEcCtD
Tretinoin—Chest pain—Doxorubicin—lung cancer	1.73e-05	0.00012	CcSEcCtD
Tretinoin—Myalgia—Doxorubicin—lung cancer	1.73e-05	0.00012	CcSEcCtD
Tretinoin—Anxiety—Doxorubicin—lung cancer	1.73e-05	0.00012	CcSEcCtD
Tretinoin—Paraesthesia—Methotrexate—lung cancer	1.72e-05	0.00012	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	1.72e-05	0.000119	CcSEcCtD
Tretinoin—Discomfort—Doxorubicin—lung cancer	1.71e-05	0.000119	CcSEcCtD
Tretinoin—Dyspnoea—Methotrexate—lung cancer	1.71e-05	0.000119	CcSEcCtD
Tretinoin—Somnolence—Methotrexate—lung cancer	1.71e-05	0.000118	CcSEcCtD
Tretinoin—Dry mouth—Doxorubicin—lung cancer	1.7e-05	0.000118	CcSEcCtD
Tretinoin—Vomiting—Docetaxel—lung cancer	1.69e-05	0.000117	CcSEcCtD
Tretinoin—Dyspepsia—Methotrexate—lung cancer	1.69e-05	0.000117	CcSEcCtD
Tretinoin—Rash—Docetaxel—lung cancer	1.68e-05	0.000116	CcSEcCtD
Tretinoin—Dermatitis—Docetaxel—lung cancer	1.68e-05	0.000116	CcSEcCtD
Tretinoin—Confusional state—Doxorubicin—lung cancer	1.68e-05	0.000116	CcSEcCtD
Tretinoin—Decreased appetite—Methotrexate—lung cancer	1.67e-05	0.000116	CcSEcCtD
Tretinoin—Headache—Docetaxel—lung cancer	1.67e-05	0.000116	CcSEcCtD
Tretinoin—Anaphylactic shock—Doxorubicin—lung cancer	1.66e-05	0.000115	CcSEcCtD
Tretinoin—Oedema—Doxorubicin—lung cancer	1.66e-05	0.000115	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Methotrexate—lung cancer	1.66e-05	0.000115	CcSEcCtD
Tretinoin—Fatigue—Methotrexate—lung cancer	1.66e-05	0.000115	CcSEcCtD
Tretinoin—Infection—Doxorubicin—lung cancer	1.65e-05	0.000114	CcSEcCtD
Tretinoin—Pain—Methotrexate—lung cancer	1.64e-05	0.000114	CcSEcCtD
Tretinoin—Shock—Doxorubicin—lung cancer	1.64e-05	0.000113	CcSEcCtD
Tretinoin—Nervous system disorder—Doxorubicin—lung cancer	1.63e-05	0.000113	CcSEcCtD
Tretinoin—Thrombocytopenia—Doxorubicin—lung cancer	1.63e-05	0.000113	CcSEcCtD
Tretinoin—Tachycardia—Doxorubicin—lung cancer	1.62e-05	0.000112	CcSEcCtD
Tretinoin—Skin disorder—Doxorubicin—lung cancer	1.61e-05	0.000112	CcSEcCtD
Tretinoin—Hyperhidrosis—Doxorubicin—lung cancer	1.61e-05	0.000111	CcSEcCtD
Tretinoin—Anorexia—Doxorubicin—lung cancer	1.58e-05	0.00011	CcSEcCtD
Tretinoin—Nausea—Docetaxel—lung cancer	1.58e-05	0.00011	CcSEcCtD
Tretinoin—Feeling abnormal—Methotrexate—lung cancer	1.58e-05	0.00011	CcSEcCtD
Tretinoin—Gastrointestinal pain—Methotrexate—lung cancer	1.57e-05	0.000109	CcSEcCtD
Tretinoin—Hypotension—Doxorubicin—lung cancer	1.55e-05	0.000108	CcSEcCtD
Tretinoin—Urticaria—Methotrexate—lung cancer	1.53e-05	0.000106	CcSEcCtD
Tretinoin—Abdominal pain—Methotrexate—lung cancer	1.52e-05	0.000105	CcSEcCtD
Tretinoin—Body temperature increased—Methotrexate—lung cancer	1.52e-05	0.000105	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Doxorubicin—lung cancer	1.51e-05	0.000105	CcSEcCtD
Tretinoin—Insomnia—Doxorubicin—lung cancer	1.5e-05	0.000104	CcSEcCtD
Tretinoin—Paraesthesia—Doxorubicin—lung cancer	1.49e-05	0.000103	CcSEcCtD
Tretinoin—Dyspnoea—Doxorubicin—lung cancer	1.48e-05	0.000103	CcSEcCtD
Tretinoin—Somnolence—Doxorubicin—lung cancer	1.48e-05	0.000102	CcSEcCtD
Tretinoin—Dyspepsia—Doxorubicin—lung cancer	1.46e-05	0.000101	CcSEcCtD
Tretinoin—Decreased appetite—Doxorubicin—lung cancer	1.45e-05	0.0001	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Doxorubicin—lung cancer	1.44e-05	9.95e-05	CcSEcCtD
Tretinoin—Fatigue—Doxorubicin—lung cancer	1.43e-05	9.94e-05	CcSEcCtD
Tretinoin—Constipation—Doxorubicin—lung cancer	1.42e-05	9.86e-05	CcSEcCtD
Tretinoin—Pain—Doxorubicin—lung cancer	1.42e-05	9.86e-05	CcSEcCtD
Tretinoin—Hypersensitivity—Methotrexate—lung cancer	1.41e-05	9.81e-05	CcSEcCtD
Tretinoin—Asthenia—Methotrexate—lung cancer	1.38e-05	9.55e-05	CcSEcCtD
Tretinoin—Feeling abnormal—Doxorubicin—lung cancer	1.37e-05	9.5e-05	CcSEcCtD
Tretinoin—Gastrointestinal pain—Doxorubicin—lung cancer	1.36e-05	9.42e-05	CcSEcCtD
Tretinoin—Pruritus—Methotrexate—lung cancer	1.36e-05	9.42e-05	CcSEcCtD
Tretinoin—Urticaria—Doxorubicin—lung cancer	1.32e-05	9.16e-05	CcSEcCtD
Tretinoin—Abdominal pain—Doxorubicin—lung cancer	1.31e-05	9.11e-05	CcSEcCtD
Tretinoin—Body temperature increased—Doxorubicin—lung cancer	1.31e-05	9.11e-05	CcSEcCtD
Tretinoin—Diarrhoea—Methotrexate—lung cancer	1.31e-05	9.11e-05	CcSEcCtD
Tretinoin—Dizziness—Methotrexate—lung cancer	1.27e-05	8.8e-05	CcSEcCtD
Tretinoin—Hypersensitivity—Doxorubicin—lung cancer	1.22e-05	8.49e-05	CcSEcCtD
Tretinoin—Vomiting—Methotrexate—lung cancer	1.22e-05	8.46e-05	CcSEcCtD
Tretinoin—Rash—Methotrexate—lung cancer	1.21e-05	8.39e-05	CcSEcCtD
Tretinoin—Dermatitis—Methotrexate—lung cancer	1.21e-05	8.38e-05	CcSEcCtD
Tretinoin—Headache—Methotrexate—lung cancer	1.2e-05	8.34e-05	CcSEcCtD
Tretinoin—Asthenia—Doxorubicin—lung cancer	1.19e-05	8.27e-05	CcSEcCtD
Tretinoin—Pruritus—Doxorubicin—lung cancer	1.18e-05	8.15e-05	CcSEcCtD
Tretinoin—Nausea—Methotrexate—lung cancer	1.14e-05	7.91e-05	CcSEcCtD
Tretinoin—Diarrhoea—Doxorubicin—lung cancer	1.14e-05	7.89e-05	CcSEcCtD
Tretinoin—Dizziness—Doxorubicin—lung cancer	1.1e-05	7.62e-05	CcSEcCtD
Tretinoin—Vomiting—Doxorubicin—lung cancer	1.06e-05	7.33e-05	CcSEcCtD
Tretinoin—Rash—Doxorubicin—lung cancer	1.05e-05	7.27e-05	CcSEcCtD
Tretinoin—Dermatitis—Doxorubicin—lung cancer	1.05e-05	7.26e-05	CcSEcCtD
Tretinoin—Headache—Doxorubicin—lung cancer	1.04e-05	7.22e-05	CcSEcCtD
Tretinoin—Nausea—Doxorubicin—lung cancer	9.87e-06	6.85e-05	CcSEcCtD
Tretinoin—CYP2C9—Metabolism—UGT1A1—lung cancer	2.77e-06	2.6e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—ALB—lung cancer	2.76e-06	2.6e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.76e-06	2.59e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—MTMR3—lung cancer	2.75e-06	2.59e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—NQO1—lung cancer	2.75e-06	2.58e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—POMC—lung cancer	2.75e-06	2.58e-05	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—AKT1—lung cancer	2.72e-06	2.56e-05	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—AKT1—lung cancer	2.72e-06	2.56e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CYP2E1—lung cancer	2.72e-06	2.55e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CYP1A1—lung cancer	2.7e-06	2.54e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ABCB1—lung cancer	2.69e-06	2.53e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—NQO1—lung cancer	2.69e-06	2.53e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PGAM1—lung cancer	2.68e-06	2.52e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ERCC2—lung cancer	2.68e-06	2.52e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—CREBBP—lung cancer	2.68e-06	2.52e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GNG11—lung cancer	2.67e-06	2.5e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.65e-06	2.49e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—TYMS—lung cancer	2.64e-06	2.48e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ENO1—lung cancer	2.63e-06	2.47e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.62e-06	2.46e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GSTM1—lung cancer	2.61e-06	2.45e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.58e-06	2.43e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CYP2E1—lung cancer	2.57e-06	2.41e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP2A7—lung cancer	2.56e-06	2.4e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—NQO1—lung cancer	2.54e-06	2.39e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PIK3CD—lung cancer	2.54e-06	2.39e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ALDOA—lung cancer	2.54e-06	2.38e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—ALB—lung cancer	2.51e-06	2.36e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SDC4—lung cancer	2.51e-06	2.35e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.49e-06	2.34e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—STK11—lung cancer	2.48e-06	2.33e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CYP1A1—lung cancer	2.48e-06	2.33e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—NCOA3—lung cancer	2.47e-06	2.32e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.47e-06	2.31e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ERCC2—lung cancer	2.46e-06	2.31e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PIK3CB—lung cancer	2.44e-06	2.29e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—STK11—lung cancer	2.42e-06	2.28e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.42e-06	2.28e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PTGS2—lung cancer	2.42e-06	2.27e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PTEN—lung cancer	2.41e-06	2.27e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ADCY1—lung cancer	2.4e-06	2.25e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ABCG2—lung cancer	2.4e-06	2.25e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP2E1—lung cancer	2.36e-06	2.21e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ENO2—lung cancer	2.35e-06	2.21e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—HPGDS—lung cancer	2.35e-06	2.21e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PPP2R1B—lung cancer	2.34e-06	2.19e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—NQO1—lung cancer	2.33e-06	2.19e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—APOA1—lung cancer	2.32e-06	2.18e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.31e-06	2.17e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—EP300—lung cancer	2.3e-06	2.16e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GSTP1—lung cancer	2.3e-06	2.16e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—STK11—lung cancer	2.29e-06	2.15e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—RRM1—lung cancer	2.28e-06	2.14e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTA3—lung cancer	2.28e-06	2.14e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSTT1—lung cancer	2.28e-06	2.14e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.28e-06	2.14e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.26e-06	2.12e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GCLC—lung cancer	2.26e-06	2.12e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP2A6—lung cancer	2.26e-06	2.12e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.25e-06	2.11e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GSTP1—lung cancer	2.24e-06	2.11e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CAT—lung cancer	2.23e-06	2.1e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PIK3CB—lung cancer	2.21e-06	2.08e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PTGS2—lung cancer	2.19e-06	2.06e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CAT—lung cancer	2.18e-06	2.05e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ABCB1—lung cancer	2.17e-06	2.04e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.15e-06	2.02e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—B4GALT5—lung cancer	2.15e-06	2.01e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ENO1—lung cancer	2.14e-06	2.01e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—TYMS—lung cancer	2.13e-06	2e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.13e-06	2e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—APOA1—lung cancer	2.13e-06	2e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ABCB1—lung cancer	2.12e-06	1.99e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GSTP1—lung cancer	2.12e-06	1.99e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3CG—lung cancer	2.12e-06	1.99e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PTEN—lung cancer	2.11e-06	1.98e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GSTM1—lung cancer	2.11e-06	1.98e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—MAPK3—lung cancer	2.1e-06	1.97e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.1e-06	1.97e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—STK11—lung cancer	2.1e-06	1.97e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTA4—lung cancer	2.09e-06	1.96e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—TYMS—lung cancer	2.09e-06	1.96e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CAT—lung cancer	2.06e-06	1.94e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GSTM1—lung cancer	2.06e-06	1.94e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.05e-06	1.93e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—MYC—lung cancer	2.05e-06	1.92e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTA2—lung cancer	2.03e-06	1.91e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—POMC—lung cancer	2.02e-06	1.89e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—EP300—lung cancer	2.01e-06	1.89e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ABCB1—lung cancer	2.01e-06	1.88e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CYP1A1—lung cancer	2e-06	1.88e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ERCC2—lung cancer	1.98e-06	1.86e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.97e-06	1.85e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—TYMS—lung cancer	1.97e-06	1.85e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CREBBP—lung cancer	1.96e-06	1.84e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTA1—lung cancer	1.96e-06	1.84e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CYP1A1—lung cancer	1.95e-06	1.84e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GSTM1—lung cancer	1.95e-06	1.83e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GSTP1—lung cancer	1.94e-06	1.82e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3CG—lung cancer	1.94e-06	1.82e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ABCC3—lung cancer	1.94e-06	1.82e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ERCC2—lung cancer	1.94e-06	1.82e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP2E1—lung cancer	1.92e-06	1.8e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PTEN—lung cancer	1.91e-06	1.8e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—NQO1—lung cancer	1.9e-06	1.78e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CAT—lung cancer	1.89e-06	1.78e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.88e-06	1.77e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—AKR1C1—lung cancer	1.88e-06	1.76e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3CD—lung cancer	1.86e-06	1.75e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.86e-06	1.74e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—POMC—lung cancer	1.85e-06	1.73e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.84e-06	1.73e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ABCB1—lung cancer	1.84e-06	1.73e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ALB—lung cancer	1.84e-06	1.73e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ERCC2—lung cancer	1.83e-06	1.72e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—EP300—lung cancer	1.83e-06	1.71e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—UGT1A1—lung cancer	1.82e-06	1.71e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—TYMS—lung cancer	1.81e-06	1.7e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CREBBP—lung cancer	1.8e-06	1.69e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GSTM1—lung cancer	1.79e-06	1.68e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GNG11—lung cancer	1.76e-06	1.65e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—APOA1—lung cancer	1.72e-06	1.61e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—STK11—lung cancer	1.71e-06	1.6e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3CD—lung cancer	1.71e-06	1.6e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PIK3CA—lung cancer	1.7e-06	1.6e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP1A1—lung cancer	1.69e-06	1.59e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ALB—lung cancer	1.68e-06	1.58e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ERCC2—lung cancer	1.68e-06	1.58e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—APOA1—lung cancer	1.68e-06	1.57e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ALDOA—lung cancer	1.68e-06	1.57e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NCOA3—lung cancer	1.63e-06	1.53e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3CB—lung cancer	1.62e-06	1.52e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PTGS2—lung cancer	1.61e-06	1.51e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.6e-06	1.51e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—APOA1—lung cancer	1.58e-06	1.49e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ADCY1—lung cancer	1.58e-06	1.49e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ABCG2—lung cancer	1.58e-06	1.49e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSTP1—lung cancer	1.58e-06	1.48e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3CG—lung cancer	1.57e-06	1.47e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—HPGDS—lung cancer	1.55e-06	1.46e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ENO2—lung cancer	1.55e-06	1.46e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.54e-06	1.45e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CAT—lung cancer	1.54e-06	1.44e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3CG—lung cancer	1.53e-06	1.44e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.53e-06	1.44e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.52e-06	1.42e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTT1—lung cancer	1.5e-06	1.41e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ABCB1—lung cancer	1.5e-06	1.41e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—POMC—lung cancer	1.49e-06	1.4e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PIK3CA—lung cancer	1.49e-06	1.4e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP2A6—lung cancer	1.49e-06	1.4e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GCLC—lung cancer	1.49e-06	1.4e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3CB—lung cancer	1.49e-06	1.4e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PTGS2—lung cancer	1.47e-06	1.38e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—TYMS—lung cancer	1.47e-06	1.38e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—POMC—lung cancer	1.46e-06	1.37e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSTM1—lung cancer	1.45e-06	1.36e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—APOA1—lung cancer	1.45e-06	1.36e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CREBBP—lung cancer	1.45e-06	1.36e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3CG—lung cancer	1.45e-06	1.36e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CREBBP—lung cancer	1.42e-06	1.33e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—AKT1—lung cancer	1.42e-06	1.33e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ENO1—lung cancer	1.41e-06	1.32e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PTEN—lung cancer	1.4e-06	1.32e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.39e-06	1.31e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—AKT1—lung cancer	1.39e-06	1.31e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP1A1—lung cancer	1.38e-06	1.29e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3CD—lung cancer	1.38e-06	1.29e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—POMC—lung cancer	1.38e-06	1.29e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ERCC2—lung cancer	1.37e-06	1.28e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ALB—lung cancer	1.36e-06	1.28e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PIK3CA—lung cancer	1.35e-06	1.27e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3CD—lung cancer	1.35e-06	1.26e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CREBBP—lung cancer	1.34e-06	1.26e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—EP300—lung cancer	1.34e-06	1.26e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ALB—lung cancer	1.33e-06	1.25e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3CG—lung cancer	1.33e-06	1.24e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PTEN—lung cancer	1.29e-06	1.21e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3CD—lung cancer	1.27e-06	1.19e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP2E1—lung cancer	1.26e-06	1.19e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—POMC—lung cancer	1.26e-06	1.19e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ALB—lung cancer	1.26e-06	1.18e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NQO1—lung cancer	1.25e-06	1.17e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CREBBP—lung cancer	1.23e-06	1.15e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—EP300—lung cancer	1.23e-06	1.15e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—AKT1—lung cancer	1.22e-06	1.14e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3CB—lung cancer	1.2e-06	1.13e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PTGS2—lung cancer	1.19e-06	1.12e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—APOA1—lung cancer	1.18e-06	1.11e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3CB—lung cancer	1.17e-06	1.1e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3CD—lung cancer	1.17e-06	1.09e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PTGS2—lung cancer	1.16e-06	1.09e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ALB—lung cancer	1.15e-06	1.08e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.13e-06	1.06e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—STK11—lung cancer	1.13e-06	1.06e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3CB—lung cancer	1.11e-06	1.04e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—AKT1—lung cancer	1.1e-06	1.04e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PTGS2—lung cancer	1.1e-06	1.03e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3CG—lung cancer	1.08e-06	1.01e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTP1—lung cancer	1.04e-06	9.79e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PTEN—lung cancer	1.04e-06	9.74e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—POMC—lung cancer	1.03e-06	9.64e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3CB—lung cancer	1.02e-06	9.54e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CAT—lung cancer	1.01e-06	9.53e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PTEN—lung cancer	1.01e-06	9.52e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PTGS2—lung cancer	1.01e-06	9.45e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CREBBP—lung cancer	1e-06	9.39e-06	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3CA—lung cancer	9.89e-07	9.29e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—EP300—lung cancer	9.89e-07	9.29e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ABCB1—lung cancer	9.87e-07	9.27e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—TYMS—lung cancer	9.7e-07	9.1e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—EP300—lung cancer	9.67e-07	9.08e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTM1—lung cancer	9.58e-07	9e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PTEN—lung cancer	9.58e-07	8.99e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3CD—lung cancer	9.49e-07	8.91e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ALB—lung cancer	9.36e-07	8.79e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—EP300—lung cancer	9.13e-07	8.57e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP1A1—lung cancer	9.09e-07	8.53e-06	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3CA—lung cancer	9.07e-07	8.51e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ERCC2—lung cancer	9.01e-07	8.46e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PTEN—lung cancer	8.78e-07	8.24e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—EP300—lung cancer	8.37e-07	7.86e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3CB—lung cancer	8.27e-07	7.76e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PTGS2—lung cancer	8.19e-07	7.69e-06	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—AKT1—lung cancer	8.08e-07	7.59e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—APOA1—lung cancer	7.79e-07	7.32e-06	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—AKT1—lung cancer	7.41e-07	6.95e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3CA—lung cancer	7.32e-07	6.87e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3CA—lung cancer	7.15e-07	6.71e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PTEN—lung cancer	7.14e-07	6.71e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3CG—lung cancer	7.12e-07	6.68e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—EP300—lung cancer	6.81e-07	6.4e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—POMC—lung cancer	6.77e-07	6.36e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3CA—lung cancer	6.76e-07	6.34e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CREBBP—lung cancer	6.6e-07	6.2e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3CD—lung cancer	6.26e-07	5.87e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3CA—lung cancer	6.19e-07	5.82e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ALB—lung cancer	6.18e-07	5.8e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—AKT1—lung cancer	5.98e-07	5.61e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—AKT1—lung cancer	5.84e-07	5.48e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—AKT1—lung cancer	5.52e-07	5.18e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3CB—lung cancer	5.45e-07	5.12e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PTGS2—lung cancer	5.4e-07	5.07e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—AKT1—lung cancer	5.06e-07	4.75e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3CA—lung cancer	5.04e-07	4.73e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PTEN—lung cancer	4.71e-07	4.42e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—EP300—lung cancer	4.49e-07	4.22e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—AKT1—lung cancer	4.12e-07	3.87e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3CA—lung cancer	3.32e-07	3.12e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—AKT1—lung cancer	2.72e-07	2.55e-06	CbGpPWpGaD
